Gilead Sciences Inc. Products & Brands - Key Offerings and Insights

Products

Category

Product

Brand

Description

Viral Vector and Plasmid DNA (BIO192B)

Yescarta (axicabtagene ciloleucel)		Yescarta is a biosynthetically produced CAR T-cell therapy for treating lrge B-cell lymphoma. Retroviral is the viral vector used to make this product.
Tecartus (Brexucabtagene autoleucel)		Tecartus is a biosynthetically produced CAR T-cell therapy approved and used for treating relapsed or refractory Mantle Cell Lymphoma and B-cell precursor acute lymphoblastic leukemia (ALL). Retroviral is the viral vector used to produce this product.

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.